BCSFVSDNA• 12 Months (Normalized)
BCSF vs DNA (Bain Capital Specialty Finance Inc. vs Ginkgo Bioworks Holdings Inc.)
Showing Closing Date Range from Oct 6, 2025 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BCSF Performance $10.9
-21.98%
Bain Capital Specialty Finance Inc.
Normalized Baseline0.00%
DNA Performance $14.98
+0.74%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
-22.72 pts
DNA outperforming by 22.72 percentage points
BCSFDNA
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BCSF DNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | BCSF Price | BCSF Gain (%) | DNA Price | DNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $10.90 | -21.98% | $14.98 | +0.74% | -22.72% |
| Oct 02, 2026 | $11.05 | -20.90% | $12.35 | -16.95% | -3.95% |
| Oct 01, 2026 | $- | $12.50 | -15.94% | - | |
| Sep 30, 2026 | $- | $12.83 | -13.72% | - | |
| Sep 29, 2026 | $- | $11.96 | -19.57% | - | |
| Sep 28, 2026 | $- | $10.46 | -29.66% | - | |
| Sep 25, 2026 | $11.08 | -20.69% | $10.66 | -28.31% | +7.62% |
| Sep 24, 2026 | $11.12 | -20.40% | $10.25 | -31.07% | +10.67% |
| Sep 23, 2026 | $11.07 | -20.76% | $8.58 | -42.30% | +21.54% |
| Sep 22, 2026 | $11.22 | -19.69% | $9.37 | -36.99% | +17.30% |
| Sep 21, 2026 | $11.21 | -19.76% | $7.98 | -46.33% | +26.57% |
| Sep 18, 2026 | $11.09 | -20.62% | $7.88 | -47.01% | +26.39% |
| Sep 17, 2026 | $11.30 | -19.11% | $7.84 | -47.28% | +28.17% |
| Sep 16, 2026 | $11.08 | -20.69% | $7.06 | -52.52% | +31.83% |
| Sep 15, 2026 | $11.07 | -20.76% | $6.99 | -52.99% | +32.23% |
Page 1 of 17